Who owns BIOVENTUS INC - A?
- Ticker: BVS
- CUSIP Number: 09075a108
Tip: Access positions for across all investors
Analyze quarterly positions in Bioventus Inc - A with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioventus Inc - A stock
Who bought or sold BIOVENTUS INC - A this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Juniper Investment Company | 6.8M | $36M | 0% | Dec 2023 |
|
| Nantahala Capital Management | 6.0M | $32M | -1% | Dec 2023 |
|
| Vanguard Group | 1.2M | $6.4M | 1% | Dec 2023 |
|
| Kent Lake Capital | 533k | $2.8M | -49% | Dec 2023 |
|
| Jacobs Levy Equity Management | 329k | $1.7M | -10% | Dec 2023 |
|
| Millennium Management | 236k | $1.2M | -31% | Dec 2023 |
|
| Marshall Wace | 191k | $1.0M | -28% | Dec 2023 |
|
| Charles Schwab Investment Management | 181k | $952k | 2% | Dec 2023 |
|
| Jane Street | 156k | $820k | 398% | Dec 2023 |
|
| Mariner Wealth Advisors | 131k | $688k | 72% | Dec 2023 |
|
| Two Sigma Advisers | 128k | $674k | 158% | Dec 2023 |
|
| Citigroup | 125k | $656k | 137% | Dec 2023 |
|
| Laurion Capital Management | 118k | $623k | 100% | Dec 2023 |
|
| Lountzis Asset Management | 100k | $527k | 0% | Dec 2023 |
|
| Citadel Advisors | 93k | $490k | 637% | Dec 2023 |
|
| Balyasny Asset Management | 87k | $458k | 100% | Dec 2023 |
|
| Two Sigma Investments | 85k | $448k | 38% | Dec 2023 |
|
| Kennedy Capital Management | 72k | $380k | 8% | Dec 2023 |
|
| Man Group | 70k | $367k | 100% | Dec 2023 |
|
| Bank of America Corporation | 67k | $353k | 75% | Dec 2023 |
|
| Barclays | 60k | $313k | 65% | Dec 2023 |
|
| Bailard | 58k | $307k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 57k | $299k | 20558% | Dec 2023 |
|
| 683 Capital Management | 56k | $297k | 100% | Dec 2023 |
|
| Massachusetts Financial Services | 55k | $291k | -3% | Dec 2023 |
|
| Cubist Systematic Strategies | 39k | $208k | -5% | Dec 2023 |
|
| Advisor Group Holdings | 38k | $200k | 0% | Dec 2023 |
|
| D. E. Shaw & Co | 36k | $189k | 100% | Dec 2023 |
|
| Goldman Sachs Group | 34k | $181k | 100% | Dec 2023 |
|
| Dimensional Fund Advisors | 31k | $163k | 55% | Dec 2023 |
|
| Hillsdale Investment Management | 28k | $145k | 100% | Dec 2023 |
|
| GSG Advisors | 27k | $133k | 56% | Mar 2024 |
|
| Moran Wealth Management | 24k | $128k | -9% | Dec 2023 |
|
| Jump Financial | 23k | $122k | 100% | Dec 2023 |
|
| Occudo Quantitative Strategies | 23k | $122k | 100% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 16k | $86k | 100% | Dec 2023 |
|
| Bank of New York Mellon | 15k | $79k | -84% | Dec 2023 |
|
| Arete Wealth Advisors | 13k | $69k | 0% | Dec 2023 |
|
| State of Wyoming | 12k | $61k | -43% | Dec 2023 |
|
| Cutler | 4.8k | $24k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 4.1k | $22k | 100% | Dec 2023 |
|
| UBS Group | 2.4k | $13k | -44% | Dec 2023 |
|
| Federated Investors | 1.8k | $9.7k | 438% | Dec 2023 |
|
| WealthCollab | 1.7k | $9.0k | 100% | Dec 2023 |
|
| Simplex Trading | 1.3k | $6.0k | -91% | Mar 2024 |
|
| Point72 Asia | 1.0k | $5.5k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 959.00 | $5.1k | 0% | Dec 2023 |
|
| Adirondack Trust | 682.00 | $3.5k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 252.00 | $1.3k | 6% | Dec 2023 |
|
| NISA Investment Advisors | 86.00 | $452.996400 | 0% | Dec 2023 |
|
Who sold out of Bioventus Inc - A?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Western Standard | Sep 2023 | 281k | $929k |
| Comprehensive Financial Management | Sep 2023 | 81k | $267k |
| T. Rowe Price Associates | Sep 2023 | 63k | $207k |
| Royce & Associates | Sep 2023 | 50k | $165k |
| Wolverine Trading | Sep 2023 | 23k | $76k |
| Virtu Financial | Sep 2023 | 20k | $66k |
| Dynamic Technology Lab Private | Sep 2023 | 13k | $43k |
| Ohio Pers | Sep 2023 | 1.2k | $4.0k |
| McGlone Suttner Wealth Management | Dec 2023 | 98.00 | $515.999400 |